Document:

Exhibit 10.2

   

  UNIT
        PURCHASE AGREEMENT

   

  THIS UNIT PURCHASE AGREEMENT (as it may from
    time to time be amended, this “Agreement”), dated as of December 8, 2020, is entered into by and among HumanCo
    Acquisition Corp., a Delaware corporation (the “Company”), and CAVU Venture Partners III, LP, a Delaware limited
    partnership (the “Purchaser”).

   

  WHEREAS, the Company intends to consummate
    an initial public offering of the Company’s units (the “Public Offering”), each unit consisting of one
    share of Class A common stock of the Company, par value $0.0001 per share (each, a “Share”), and one-half of
    one redeemable warrant (each, a “Fractional Warrant”), each whole warrant entitling the holder to purchase one
    Share at an exercise price of $11.50 per Share, as set forth in the Company’s Registration Statements on Form S-1, filed
    with the U.S. Securities and Exchange Commission (the “SEC”), File Numbers 333-250630 and 333-251205 (as amended
    and collectively, the “Registration Statement”), under the Securities Act of 1933, as amended (the “Securities
      Act”).

   

  WHEREAS, the Purchaser has agreed to
    purchase, at a price of $10.00 per unit, an aggregate of 2,500,000 units (the “CAVU Units”). Each CAVU Unit
    is identical to the units to be sold in the Public Offering, except as described in the Registration Statement.

   

  NOW THEREFORE, in consideration of the
    mutual promises contained in this Agreement and other good and valuable consideration, the receipt and sufficiency of which are
    hereby acknowledged, the parties to this Agreement hereby, intending legally to be bound, agree as follows:

   

  AGREEMENT

   

  Section 1. Authorization, Purchase and Sale;
      Terms of the CAVU Units.

   

  A. Authorization of the CAVU Units.
    The Company has duly authorized the issuance and sale of the CAVU Units to the Purchaser.

   

  B. Purchase and Sale of the CAVU
      Units.

   

  On the date of the consummation of the
    Public Offering (the “IPO Closing Date”), the Company shall issue and sell to the Purchaser, and the Purchaser
    shall purchase from the Company, 2,500,000 CAVU Units at a price of $10.00 per unit for an aggregate purchase price of $25,000,000
    (the “Purchase Price”). The Purchaser shall pay the Purchase Price by wire transfer of immediately available
    funds in accordance with the Company’s wiring instructions, at least one (1) business day prior to the IPO Closing Date.
    On the IPO Closing Date, upon the payment by the Purchaser of the Purchase Price, by wire transfer of immediately available funds
    to the Company, the Company, at its option, shall deliver a certificate evidencing the CAVU Units purchased on such date duly registered
    in the Purchaser’s name to the Purchaser or effect such delivery in book-entry form.

   

  C. Terms of the CAVU Units.

   

  (i) The Shares underlying the CAVU Units
    (the “CAVU Shares”) shall have the terms set forth in the Company’s Amended and Restated Certificate of
    Incorporation (the “Charter”) and shall be subject to the terms of a letter agreement to be entered into by
    the Company, the Purchaser and the other parties thereto, in connection with the Public Offering (the “Letter Agreement”).

   

  (ii) The Warrants underlying the CAVU
    Units (the “CAVU Warrants”) shall have the terms set forth in a Warrant Agreement to be entered into by the
    Company and a warrant agent, in connection with the Public Offering (the “Warrant Agreement”), and shall be
    subject to the terms of the Letter Agreement.

   

  
  
    	 

  

  
     

  

  
    

  (iii) At the time of, or prior to, the
    IPO Closing Date, the Company, the Purchaser and the other parties thereto shall enter into a registration and stockholder rights
    agreement (the “Registration and Stockholder Rights Agreement”) pursuant to which the Company will grant certain
    registration rights to the Purchaser relating to the CAVU Shares and CAVU Warrants.

   

  Section 2. Representations and Warranties
      of the Company.

   

  As a material inducement to the Purchaser to
    enter into this Agreement and to purchase the CAVU Units, the Company hereby represents and warrants to the Purchaser (which representations
    and warranties shall survive the IPO Closing Date) that:

   

  A. Incorporation and Corporate
      Power. The Company is a corporation duly incorporated, validly existing and in good standing under the laws of the State of
    Delaware and is qualified to do business in every jurisdiction in which the failure to so qualify would reasonably be expected
    to have a material adverse effect on the financial condition, operating results or assets of the Company. The Company possesses
    all requisite corporate power and authority necessary to carry out the transactions contemplated by this Agreement, the Charter
    and the Warrant Agreement.

   

  B. Authorization; No Breach.

   

  (i) The execution, delivery and performance
    of this Agreement and the CAVU Units have been duly authorized by the Company as of the IPO Closing Date. This Agreement constitutes
    the valid and binding obligation of the Company, enforceable in accordance with its terms, subject to bankruptcy, insolvency, fraudulent
    conveyance, reorganization, moratorium and other laws of general applicability relating to or affecting creditors’ rights
    and to general equitable principles (whether considered in a proceeding in equity or law). Upon issuance in accordance with, and
    payment pursuant to, the terms of the Charter, the Warrant Agreement and this Agreement, the CAVU Units will constitute valid and
    binding obligations of the Company, enforceable in accordance with their terms as of the IPO Closing Date.

   

  (ii) The execution and delivery by the
    Company of this Agreement and the CAVU Units, the issuance and sale of the CAVU Units, the issuance of the CAVU Shares upon exercise
    of the CAVU Warrants and the fulfillment of and compliance with the respective terms hereof and thereof by the Company, do not
    and will not as of the IPO Closing Date (a) conflict with or result in a breach of the terms, conditions or provisions of, (b)
    constitute a default under, (c) result in the creation of any lien, security interest, charge or encumbrance upon the Company’s
    capital stock or assets under, (d) result in a violation of, or (e) require any authorization, consent, approval, exemption or
    other action by or notice or declaration to, or filing with, any court or administrative or governmental body or agency pursuant
    to the certificate of incorporation or the bylaws of the Company (in effect on the date hereof or as may be amended prior to completion
    of the Public Offering) or any material law, statute, rule or regulation to which the Company is subject, or any agreement, order,
    judgment or decree to which the Company is subject, except for any filings required after the date hereof under federal or state
    securities laws.

   

  C. Title to Securities. Upon
    issuance in accordance with, and payment pursuant to, the terms hereof and the Warrant Agreement, the CAVU Shares issuable upon
    exercise of the CAVU Warrants will be duly and validly issued, fully paid and nonassessable. Upon issuance in accordance with,
    and payment pursuant to, the terms hereof and the Warrant Agreement, the Purchaser will have good title to the CAVU Warrants purchased
    by it and the CAVU Shares issuable upon exercise of such CAVU Warrants, free and clear of all liens, claims and encumbrances of
    any kind, other than (i) transfer restrictions hereunder and under the other agreements contemplated hereby, (ii) transfer restrictions
    under federal and state securities laws, and (iii) liens, claims or encumbrances imposed due to the actions of the Purchaser.

   

  
  
    	 

  

  
     

  

  
    

  D. Governmental Consents. No
    permit, consent, approval or authorization of, or declaration to or filing with, any governmental authority is required in connection
    with the execution, delivery and performance by the Company of this Agreement or the consummation by the Company of any other transactions
    contemplated hereby.

   

  E. Regulation D Qualification.
    Neither the Company nor, to its actual knowledge, any of its affiliates, members, officers, directors or beneficial shareholders
    of 20% or more of its outstanding securities, has experienced a disqualifying event as enumerated pursuant to Rule 506(d) of Regulation
    D under the Securities Act.

   

  Section 3. Representations and Warranties
      of the Purchaser.

   

  As a material inducement to the Company to enter
    into this Agreement and to issue and sell the CAVU Units to the Purchaser, the Purchaser hereby represents and warrants to the
    Company (which representations and warranties shall survive the IPO Closing Date) that:

   

  A. Organization and Requisite Authority.
    The Purchaser possesses all requisite power and authority necessary to carry out the transactions contemplated by this Agreement.

   

  B. Authorization; No Breach.

   

  (i) This Agreement constitutes a valid
    and binding obligation of the Purchaser, enforceable in accordance with its terms, subject to bankruptcy, insolvency, fraudulent
    conveyance, reorganization, moratorium and other laws of general applicability relating to or affecting creditors’ rights
    and to general equitable principles (whether considered in a proceeding in equity or law).

   

  (ii) The execution and delivery by the
    Purchaser of this Agreement and the fulfillment of and compliance with the terms hereof by the Purchaser does not and shall not
    as of the IPO Closing Date (a) conflict with or result in a breach by the Purchaser of the terms, conditions or provisions of,
    (b) constitute a default under, (c) result in the creation of any lien, security interest, charge or encumbrance upon the Purchaser’s
    equity or assets under, (d) result in a violation of, or (e) require any authorization, consent, approval, exemption or other action
    by or notice or declaration to, or filing with, any court or administrative or governmental body or agency pursuant to the Purchaser’s
    organizational documents in effect on the date hereof or as may be amended prior to completion of the contemplated Public Offering,
    or any material law, statute, rule or regulation to which the Purchaser is subject, or any agreement, instrument, order, judgment
    or decree to which the Purchaser is subject, except for any filings required after the date hereof under federal or state securities
    laws.

   

  C. Investment Representations.

   

  (i) The Purchaser is acquiring the CAVU
    Units and, upon exercise of the CAVU Warrants, the CAVU Shares issuable upon such exercise (collectively, the “Securities”)
    for its own account, for investment purposes only and not with a view towards, or for resale in connection with, any public sale
    or distribution thereof.

   

  (ii) The Purchaser is an “accredited
    investor” as such term is defined in Rule 501(a)(3) of Regulation D, and the Purchaser has not experienced a disqualifying
    event as enumerated pursuant to Rule 506(d) of Regulation D under the Securities Act.

   

  (iii) The Purchaser understands that
    the Securities are being offered and will be sold to it in reliance on specific exemptions from the registration requirements of
    the United States federal and state securities laws and that the Company is relying upon the truth and accuracy of, and the Purchaser’s
    compliance with, the representations and warranties of the Purchaser set forth herein in order to determine the availability of
    such exemptions and the eligibility of the Purchaser to acquire such Securities.

   

  
  
    	 

  

  
     

  

  
    

  (iv) The Purchaser did not decide to
    enter into this Agreement as a result of any general solicitation or general advertising within the meaning of Rule 502(c) under
    the Securities Act.

   

  (v) The Purchaser has been furnished
    with all materials relating to the business, finances and operations of the Company and materials relating to the offer and sale
    of the Securities which have been requested by the Purchaser. The Purchaser has been afforded the opportunity to ask questions
    of the executive officers and directors of the Company. The Purchaser understands that its investment in the Securities involves
    a high degree of risk and it has sought such accounting, legal and tax advice as it has considered necessary to make an informed
    investment decision with respect to the acquisition of the Securities.

   

  (vi) The Purchaser understands that
    no United States federal or state agency or any other government or governmental agency has passed on or made any recommendation
    or endorsement of the Securities or the fairness or suitability of the investment in the Securities by the Purchaser nor have such
    authorities passed upon or endorsed the merits of the offering of the Securities.

   

  (vii) The Purchaser understands that:
    (a) the Securities have not been and are not being registered under the Securities Act or any state securities laws, and may not
    be offered for sale, sold, assigned or transferred unless (1) subsequently registered thereunder or (2) sold in reliance on an
    exemption therefrom; and (b) except as specifically set forth in the Registration and Stockholder Rights Agreement, neither the
    Company nor any other person is under any obligation to register the Securities under the Securities Act or any state securities
    laws or to comply with the terms and conditions of any exemption thereunder. In this regard, the Purchaser understands that the
    SEC has taken the position that promoters or affiliates of a blank check company and their transferees, both before and after an
    initial business combination, are deemed to be “underwriters” under the Securities Act when reselling the securities
    of a blank check company. Based on that position, Rule 144 adopted pursuant to the Securities Act would not be available for resale
    transactions of the Securities despite technical compliance with the requirements of such Rule, and the Securities can be resold
    only through a registered offering or in reliance upon another exemption from the registration requirements of the Securities Act.

   

  (viii) The Purchaser has such knowledge
    and experience in financial and business matters, knowledge of the high degree of risk associated with investments in the securities
    of companies in the development stage such as the Company, is capable of evaluating the merits and risks of an investment in the
    Securities and is able to bear the economic risk of an investment in the Securities in the amount contemplated hereunder for an
    indefinite period of time. The Purchaser has adequate means of providing for its current financial needs and contingencies and
    will have no current or anticipated future needs for liquidity which would be jeopardized by the investment in the Securities.
    The Purchaser can afford a complete loss of its investments in the Securities.

   

  D. No Conflicts. The execution, delivery and performance
    of this Agreement and the consummation by Purchaser of the transactions contemplated hereby do not violate, conflict with or constitute
    a default under (i) Purchaser’s charter documents, (ii) any agreement or instrument to which Subscriber is a party or (iii)
    any law, statute, rule or regulation to which Purchaser is subject, or any agreement, order, judgment or decree to which Purchaser
    is subject.

   

  E. No Legal Advice from Company. Purchaser acknowledges
    it has had the opportunity to review this Agreement and the transactions contemplated by this Agreement and the other agreements
    entered into between the parties hereto with Purchaser’s own legal counsel and investment and tax advisors. Except for any
    statements or representations of the Company made in this Agreement and the other agreements entered into between the parties hereto,
    Purchaser is relying solely on such counsel and advisors and not on any statements or representations of the Company or any of
    its representatives or agents for legal, tax or investment advice with respect to this investment, the transactions contemplated
    by this Agreement or the securities laws of any jurisdiction.

   

  
  
    	 

  

  
     

  

  
    

  Section 4. Conditions of the Purchaser’s
      Obligations.

   

  The obligations of the Purchaser to purchase
    and pay for the CAVU Units are subject to the fulfillment, on or before the IPO Closing Date, of each of the following conditions:

   

  A. Representations and Warranties.
    The representations and warranties of the Company contained in Section 2 shall be true and correct at and as of the IPO Closing
    Date as though then made.

   

  B. Performance. The Company
    shall have performed and complied with all agreements, obligations and conditions contained in this Agreement that are required
    to be performed or complied with by it on or before the IPO Closing Date.

   

  C. No Injunction. No litigation,
    statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed
    by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization having authority over
    the matters contemplated hereby, which prohibits the consummation of any of the transactions contemplated by this Agreement, the
    Charter or the Warrant Agreement.

   

  D. Charter, Warrant Agreement and
      Registration and Stockholder Rights Agreement. The Company shall have entered into the Charter, the Warrant Agreement and the
    Registration and Stockholder Rights Agreement, in each case on terms satisfactory to the Purchaser.

   

  Section 5. Conditions of the Company’s
      Obligations.

   

  The obligations of the Company to the Purchaser
    under this Agreement are subject to the fulfillment, on or before the IPO Closing Date, of each of the following conditions:

   

  A. Representations and Warranties.
    The representations and warranties of the Purchaser contained in Section 3 shall be true and correct at and as of the IPO Closing
    Date as though then made.

   

  B. Performance. The Purchaser
    shall have performed and complied with all agreements, obligations and conditions contained in this Agreement that are required
    to be performed or complied with by the Purchaser on or before the IPO Closing Date.

   

  C. Corporate Consents. The
    Company shall have obtained the consent of its Board of Directors authorizing the execution, delivery and performance of this Agreement,
    the Charter and the Warrant Agreement and the issuance and sale of the CAVU Units hereunder.

   

  D. No Injunction. No litigation,
    statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed
    by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization having authority over
    the matters contemplated hereby, which prohibits the consummation of any of the transactions contemplated by this Agreement, the
    Charter or the Warrant Agreement.

   

  E. Charter, Warrant Agreement and
      Registration and Stockholder Rights Agreement. The Company shall have entered into the Charter, the Warrant Agreement and the
    Registration and Stockholder Rights Agreement, in each case on terms satisfactory to the Company.

   

  Section 6. Termination.

   

  This Agreement may be terminated by the Company
    or the Purchaser at any time after March 31, 2021 upon written notice to the other party hereto if the closing of the Public Offering
    does not occur prior to such date.

   

  Section 7. Survival of Representations and
      Warranties.

   

  All of the representations and warranties contained
    herein shall survive the IPO Closing Date.

   

  
  
    	 

  

  
     

  

  
    

  Section 8. Definitions.

   

  Terms used but not otherwise defined in this
    Agreement shall have the meaning assigned to such terms in the Registration Statement.

   

  Section 9. Miscellaneous.

   

  A. Successors and Assigns.
    Except as otherwise expressly provided herein, all covenants and agreements contained in this Agreement by or on behalf of any
    of the parties hereto shall bind and inure to the benefit of the respective successors of the parties hereto whether so expressed
    or not. Notwithstanding the foregoing or anything to the contrary herein, the parties may not assign this Agreement, other than
    assignments by the Purchaser to affiliates thereof (including, without limitation one or more of its members).

   

  B. Severability. Whenever possible,
    each provision of this Agreement shall be interpreted in such manner as to be effective and valid under applicable law, but if
    any provision of this Agreement is held to be prohibited by or invalid under applicable law, such provision shall be ineffective
    only to the extent of such prohibition or invalidity, without invalidating the remainder of this Agreement.

   

  C. Counterparts. This Agreement
    may be executed simultaneously in two or more counterparts, none of which need contain the signatures of more than one party, but
    all such counterparts taken together shall constitute one and the same agreement. A signed copy of this Agreement delivered by
    facsimile, e-mail or other means of electronic transmission shall be deemed to have the same legal effect as delivery of an original
    signed copy of this Agreement.

   

  D. Descriptive Headings; Interpretation.
    The descriptive headings of this Agreement are inserted for convenience only and do not constitute a substantive part of this Agreement.
    The use of the word “including” in this Agreement shall be by way of example rather than by limitation.

   

  E. Governing Law. This Agreement
    shall be deemed to be a contract made under the laws of the State of New York and for all purposes shall be construed in accordance
    with the internal laws of the State of New York, without giving effect to conflicts of law principles that would result in the
    application of the laws of another jurisdiction.

   

  F. Amendments. This Agreement
    may not be amended, modified or waived as to any particular provision, except by a written instrument executed by all parties hereto.

   

  [Signature page follows]

   

  
  
    	 

  

  
     

  

  
   

  IN WITNESS WHEREOF, the parties hereto have
    executed this Agreement to be effective as of the date first set forth above.

   

  	 	COMPANY:
	 	 
	 	HUMANCO ACQUISITION CORP.
	 	 
	 	By:	/s/ Amy Zipper
	 	Name:	 Amy Zipper
	 	Title:	 Chief Operating Officer 
	 	 	 
	 	PURCHASER:
	 	 
	 	
          CAVU Venture Partners III, LP

           

          By: CAVU Venture partners gp iii, lp

          its: general partner

           

          by: cavu venture partners gp iii, llc

          its: general partner

        
	 	 
	 	By:	/s/ Brett Thomas
	 	Name:	 Brett Thomas
	 	Title:	 Managing Partner

   

  [Signature Page to CAVU Units Purchase Agreement]Exhibit 10.3

   

  INVESTMENT
        MANAGEMENT TRUST AGREEMENT

   

  This Investment Management Trust Agreement (this
    “Agreement”) is made effective as of December 9, 2020, by and between HumanCo Acquisition Corp., a Delaware
    corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York limited purpose
    trust company (the “Trustee”).

   

  WHEREAS, the Company’s registration
    statements on Form S-1, File Nos. 333-250630 and 333-251205 (collectively, the “Registration Statement”)
    and prospectus (the “Prospectus”) for the initial public offering of the Company’s units (the “Units”),
    each of which consists of one share of the Company’s Class A common stock, par value $0.0001 per share (the “Common
        Stock”), and one-half of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one
    share of Common Stock, subject to adjustment (such initial public offering hereinafter referred to as the “Offering”),
    has been declared effective as of the date hereof by the U.S. Securities and Exchange Commission;

   

  WHEREAS, the Company has entered into
    an Underwriting Agreement, dated December 8, 2020 (the “Underwriting Agreement”), with Citigroup Global
    Markets Inc. as the underwriter (the “Underwriter”);

   

  WHEREAS, as described in the Prospectus,
    $275,000,000 of the gross proceeds of the Offering, the sale of the Private Placement Warrants (as defined in the Underwriting
    Agreement) and the sale of the CAVU Units (as defined in the Underwriting Agreement) (or $312,500,000, if the Underwriter’s
    over-allotment option is exercised in full) will be delivered to the Trustee to be deposited and held in a segregated trust account
    located at all times in the United States (the “Trust Account”) for the benefit of the Company, the holders
    of the Common Stock included in the Units issued in the Offering (the “Public Stockholders”),
    the holders of the Common Stock included in the CAVU Units (the “CAVU Stockholder”) and the Underwriter
    as hereinafter provided (the amount to be delivered to the Trustee (and any interest subsequently earned thereon) is referred to
    herein as the “Property,” the Public Stockholders and CAVU Stockholder, for whose benefit the
    Trustee shall hold the Property, will be referred to collectively as the “Covered Stockholders,”
    and the Covered Stockholders, the Company and the Underwriter will be referred to together as the “Beneficiaries”);

   

  WHEREAS, pursuant to the Underwriting
    Agreement, a portion of the Property equal to $8,750,000, or $10,062,500 if the Underwriter’s over-allotment option is exercised
    in full, is attributable to deferred underwriting discounts and commissions (the “Deferred Discount”)
    that will be payable by the Company to the Underwriter upon and concurrently with the consummation of the Business Combination
    (as defined below); and

   

  WHEREAS, the Company and the Trustee
    desire to enter into this Agreement to set forth the terms and conditions pursuant to which the Trustee shall hold the Property.

   

  NOW THEREFORE, IT IS AGREED:

   

  1. Agreements and Covenants of Trustee.
    The Trustee hereby agrees and covenants to:

   

  (a) Hold the Property in trust for the Beneficiaries
    in accordance with the terms of this Agreement in the Trust Account, which Trust Account shall be established by the Trustee in
    the United States at J.P. Morgan Chase Bank, N.A. (or at another U.S. chartered commercial bank with consolidated assets of $100
    billion or more) and at a brokerage institution selected by the Trustee that is reasonably satisfactory to the Company;

   

  (b) Manage, supervise and administer the Trust
    Account subject to the terms and conditions set forth herein;

   

  (c) In a timely manner, upon the written instruction
    of the Company, invest and reinvest the Property solely in United States government securities within the meaning of Section 2(a)(16)
    of the Investment Company Act of 1940, as amended (the “Investment Company Act”), having a maturity of
    185 days or less, or in money market funds meeting the conditions of paragraphs (d)(1), (d)(2), (d)(3) and (d)(4) of Rule 2a-7
    promulgated under the Investment Company Act (or any successor rule), which invest only in direct U.S. government treasury obligations,
    as determined by the Company; it being understood that the Trust Account will earn no interest while account funds are uninvested
    awaiting the Company’s instructions hereunder and the Trustee may earn bank credits or other consideration during such periods;

   

  
  
    	 

  

  
     

  

  
    

  (d) Collect and receive, when due, all principal,
    interest or other income arising from the Property, which shall become part of the “Property,” as such
    term is used herein;

   

  (e) Promptly notify the Company and the Underwriter
    of all communications received by the Trustee with respect to any Property requiring action by the Company;

   

  (f) Supply any necessary information or documents
    as may be requested by the Company (or its authorized agents) in connection with the Company’s preparation of the tax returns
    relating to assets held in the Trust Account;

   

  (g) Participate in any plan or proceeding for
    protecting or enforcing any right or interest arising from the Property if, as and when instructed by the Company to do so;

   

  (h) Render to the Company, and to such other persons
    as the Company may instruct, monthly written statements of the activities of, and amounts in, the Trust Account reflecting all
    receipts and disbursements of the Trust Account;

   

  (i) Commence liquidation of the Trust Account
    only after and promptly after (x) receipt of, and only in accordance with, the terms of a letter from the Company (“Termination
        Letter”) in a form substantially similar to that attached hereto as either Exhibit A or Exhibit B, as applicable,
    signed on behalf of the Company by any of its Chief Executive Officer, Chief Financial Officer, Chief Operating Officer, President,
    Executive Vice President, Vice President, Secretary, Executive Co-Chairman or Co-Chairman of the Board of Directors of the Company
    (the “Board”) or other authorized officer of the Company, and complete the liquidation of the Trust Account
    and distribute the Property in the Trust Account, including interest not previously released to the Company to pay its franchise
    and income taxes (less up to $100,000 of interest that may be released to the Company to pay dissolution expenses in the case of
    a Termination Letter in the form of Exhibit B hereto), only as directed in the Termination Letter and the other documents referred
    to therein, or (y) upon the date which is, the later of (1) 24 months after the closing of the Offering and (2) such later date
    as may be approved by the Company’s stockholders in accordance with the Company’s amended and restated certificate
    of incorporation if a Termination Letter has not been received by the Trustee prior to such date, in which case the Trust Account
    shall be liquidated in accordance with the procedures set forth in the form of letter attached hereto as Exhibit B and the Property
    in the Trust Account, including interest not previously released to the Company to pay its franchise and income taxes (less up
    to $100,000 of interest that may be released to the Company to pay dissolution expenses) shall be distributed to the Covered Stockholders
    of record as of such date;

   

  (j) Upon written request from the Company, which
    may be given from time to time in a form substantially similar to that attached hereto as Exhibit C, withdraw from the Trust Account
    and distribute to the Company the amount of interest earned on the Property requested by the Company to cover any tax obligation,
    including any franchise tax obligations, owed by the Company as a result of assets of the Company or interest or other income earned
    on the Property, which amount shall be delivered directly to the Company by electronic funds transfer or other method of prompt
    payment, and the Company shall forward such payment to the relevant taxing authority; provided, however, that to the extent there
    is not sufficient cash in the Trust Account to pay such tax obligation, the Trustee shall liquidate such assets held in the Trust
    Account as shall be designated by the Company in writing to make such distribution, so long as such distribution shall not result
    in a reduction in the principal price per share amount initially deposited in the Trust Account; provided, further, that if the
    tax to be paid is a franchise tax, the written request by the Company to make such distribution shall be accompanied by a copy
    of the franchise tax bill from the State of Delaware for the Company (it being acknowledged and agreed that any such amount in
    excess of interest income earned on the Property shall not be payable from the Trust Account). The written request of the Company
    referenced above shall constitute presumptive evidence that the Company is entitled to said funds, and the Trustee shall have no
    responsibility to look beyond said request;

   

  
  
    	 

  

  
     

  

  
    

  (k) Upon written request from the Company, which
    may be given from time to time in a form substantially similar to that attached hereto as Exhibit D, distribute on behalf of the
    Company the amount requested by the Company to be used to redeem shares of Common Stock from Public Stockholders properly submitted
    for redemption in connection with a stockholder vote to approve an amendment to the Company’s amended and restated certificate
    of incorporation to (i) modify the substance or timing of the Company’s obligation to allow redemption in connection with
    an initial Business Combination or the Company’s obligation to redeem 100% of the shares of Common Stock included in the
    Units sold in the Offering (the “Public Shares”) and the shares of Common Stock included in the CAVU
    Units (the “CAVU Shares”) if the Company has not consummated an initial Business Combination within the
    time period set forth in the Company’s amended and restated certificate of incorporation or (ii) with respect to any other
    provision relating to stockholders’ rights or pre-initial Business Combination activity; and

   

  (l) Not make any withdrawals or distributions
    from the Trust Account other than pursuant to Section 1(i), (j) or (k) above.

   

  2. Agreements and Covenants of the Company.
    The Company hereby agrees and covenants to:

   

  (a) Give all instructions to the Trustee hereunder
    in writing, signed by the Company’s Executive Co-Chairman or Co-Chairman of the Board, Chief Executive Officer, Chief Financial
    Officer, Chief Operating Officer, President, Executive Vice President, Vice President or Secretary. In addition, except with respect
    to its duties under Sections 1(i), 1(j) and 1(k) hereof, the Trustee shall be entitled to rely on, and shall be protected in relying
    on, any verbal or telephonic advice or instruction which it, in good faith and with reasonable care, believes to be given by any
    one of the persons authorized above to give written instructions, provided that the Company shall promptly confirm such instructions
    in writing;

   

  (b) Subject to Section 4 hereof, hold the Trustee
    harmless and indemnify the Trustee from and against any and all expenses, including reasonable counsel fees and disbursements,
    or losses suffered by the Trustee in connection with any action taken by it hereunder and in connection with any action, suit or
    other proceeding brought against the Trustee involving any claim, or in connection with any claim or demand, which in any way arises
    out of or relates to this Agreement, the services of the Trustee hereunder, or the Property or any interest earned on the Property,
    except for expenses and losses resulting from the Trustee’s gross negligence, fraud or willful misconduct. Promptly after
    the receipt by the Trustee of notice of demand or claim or the commencement of any action, suit or proceeding, pursuant to which
    the Trustee intends to seek indemnification under this Section 2(b), it shall notify the Company in writing of such claim (hereinafter
    referred to as the “Indemnified Claim”). The Trustee shall have the right to conduct and manage the defense
    against such Indemnified Claim; provided that the Trustee shall obtain the consent of the Company with respect to the selection
    of counsel, which consent shall not be unreasonably withheld. The Trustee may not agree to settle any Indemnified Claim without
    the prior written consent of the Company, which such consent shall not be unreasonably withheld. The Company may participate in
    such action with its own counsel;

   

  (c) Pay the Trustee the fees set forth on Schedule
    A hereto, including an initial acceptance fee, annual administration fee and transaction processing fee, which fees shall be subject
    to modification by the parties from time to time. It is expressly understood that the Property shall not be used to pay such fees
    unless and until the closing of the Business Combination. The Company shall pay the Trustee the initial acceptance fee and the
    first annual administration fee at the consummation of the Offering. The Company shall not be responsible for any other fees or
    charges of the Trustee except as set forth in this Section 2(c), Schedule A and as may be provided in Section 2(b) hereof;

   

  (d) In connection with any vote of the Company’s
    stockholders regarding a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business
    combination involving the Company and one or more businesses (a “Business Combination”), provide to the
    Trustee an affidavit or certificate of the inspector of elections for the stockholder meeting verifying the vote of such stockholders
    regarding such Business Combination;

   

  (e) Provide the Underwriter with a copy of any
    Termination Letter(s) and/or any other correspondence that is sent to the Trustee with respect to any proposed withdrawal from
    the Trust Account promptly after it issues the same;

   

  
  
    	 

  

  
     

  

  
    

  (f) Unless otherwise agreed between the Company
    and the Underwriter, ensure that any Instruction Letter (as defined in Exhibit A) delivered in connection with a Termination Letter
    in the form of Exhibit A expressly provides that the Deferred Discount is paid directly to the account or accounts directed by
    the Underwriter prior to any transfer of the funds held in the Trust Account to the Company or any other person;

   

  (g) Instruct the Trustee to make only those distributions
    that are permitted under this Agreement, and refrain from instructing the Trustee to make any distributions that are not permitted
    under this Agreement; and

   

  (h) Within five (5) business days after the Underwriter
    exercises its over-allotment option in connection with the Offering (or any unexercised portion thereof) or such over-allotment
    option expires, provide the Trustee with a notice in writing of the total amount of the Deferred Discount, which shall in no event
    be less than $8,750,000.

   

  3. Limitations of Liability. The Trustee
    shall have no responsibility or liability to:

   

  (a) Imply obligations, perform duties, inquire
    or otherwise be subject to the provisions of any agreement or document other than this Agreement and that which is expressly set
    forth herein;

   

  (b) Take any action with respect to the Property,
    other than as directed in Section 1 hereof, and the Trustee shall have no liability to any third party except for liability arising
    out of the Trustee’s gross negligence, fraud or willful misconduct;

   

  (c) Institute any proceeding for the collection
    of any principal and income arising from, or institute, appear in or defend any proceeding of any kind with respect to, any of
    the Property unless and until it shall have received instructions from the Company given as provided herein to do so and the Company
    shall have advanced or guaranteed to it funds sufficient to pay any expenses incident thereto;

   

  (d) Refund any depreciation in principal of any
    Property;

   

  (e) Assume that the authority of any person designated
    by the Company to give instructions hereunder shall not be continuing unless provided otherwise in such designation, or unless
    the Company shall have delivered a written revocation of such authority to the Trustee;

   

  (f) The other parties hereto or to anyone else
    for any action taken or omitted by it, or any action suffered by it to be taken or omitted, in good faith and in the Trustee’s
    best judgment, except for the Trustee’s gross negligence, fraud or willful misconduct. The Trustee may rely conclusively
    and shall be protected in acting upon any order, notice, demand, certificate, opinion or advice of counsel (including counsel chosen
    by the Trustee, which counsel may be the Company’s counsel), statement, instrument, report or other paper or document (not
    only as to its due execution and the validity and effectiveness of its provisions, but also as to the truth and acceptability of
    any information therein contained) which the Trustee believes, in good faith and with reasonable care, to be genuine and to be
    signed or presented by the proper person or persons. The Trustee shall not be bound by any notice or demand, or any waiver, modification,
    termination or rescission of this Agreement or any of the terms hereof, unless evidenced by a written instrument delivered to the
    Trustee, signed by the proper party or parties and, if the duties or rights of the Trustee are affected, unless it shall give its
    prior written consent thereto;

   

  (g) Verify the accuracy of the information contained
    in the Registration Statement;

   

  (h) Provide any assurance that any Business Combination
    entered into by the Company or any other action taken by the Company is as contemplated by the Registration Statement;

   

  (i) File information returns with respect to the
    Trust Account with any local, state or federal taxing authority or provide periodic written statements to the Company documenting
    the taxes payable by the Company, if any, relating to any interest income earned on the Property;

   

  
  
    	 

  

  
     

  

  
    

  (j) Prepare, execute and file tax reports, income
    or other tax returns and pay any taxes with respect to any income generated by, and activities relating to, the Trust Account,
    regardless of whether such tax is payable by the Trust Account or the Company, including, but not limited to, franchise and income
    tax obligations, except pursuant to Section 1(j) hereof; or

   

  (k) Verify calculations, qualify or otherwise
    approve the Company’s written requests for distributions pursuant to Sections 1(i), 1(j) or 1(k) hereof.

   

  4. Trust Account Waiver. The Trustee
    has no right of set-off or any right, title, interest or claim of any kind (“Claim”) to, or to any monies
    in, the Trust Account, and hereby irrevocably waives any Claim to, or to any monies in, the Trust Account that it may have now
    or in the future. In the event the Trustee has any Claim against the Company under this Agreement, including, without limitation,
    under Section 2(b) or Section 2(c) hereof, the Trustee shall pursue such Claim solely against the Company and its assets outside
    the Trust Account and not against the Property or any monies in the Trust Account.

   

  5. Termination. This Agreement shall
    terminate as follows:

   

  (a) If the Trustee gives written notice to the
    Company that it desires to resign under this Agreement, the Company shall use its reasonable efforts to locate a successor trustee,
    pending which the Trustee shall continue to act in accordance with this Agreement. At such time that the Company notifies the Trustee
    that a successor trustee has been appointed by the Company and has agreed to become subject to the terms of this Agreement, the
    Trustee shall transfer the management of the Trust Account to the successor trustee, including but not limited to the transfer
    of copies of the reports and statements relating to the Trust Account, whereupon this Agreement shall terminate; provided, however,
    that in the event that the Company does not locate a successor trustee within ninety (90) days of receipt of the resignation notice
    from the Trustee, the Trustee may submit an application to have the Property deposited with any court in the State of New York
    or with the United States District Court for the Southern District of New York and upon such deposit, the Trustee shall be immune
    from any liability whatsoever; or

   

  (b) At such time that the Trustee has completed
    the liquidation of the Trust Account and its obligations in accordance with the provisions of Section 1(i) hereof (which section
    may not be amended under any circumstances) and distributed the Property in accordance with the provisions of the Termination Letter,
    this Agreement shall terminate except with respect to Section 2(b).

   

  6. Miscellaneous.

   

  (a) The Company and the Trustee each acknowledge
    that the Trustee will follow the security procedures set forth below with respect to funds transferred from the Trust Account.
    The Company and the Trustee will each restrict access to confidential information relating to such security procedures to authorized
    persons. Each party must notify the other party immediately if it has reason to believe unauthorized persons may have obtained
    access to such confidential information, or of any change in its authorized personnel. In executing funds transfers, the Trustee
    shall rely upon all information supplied to it by the Company, including, account names, account numbers, and all other identifying
    information relating to a Beneficiary, Beneficiary’s bank or intermediary bank. Except for any liability arising out of the
    Trustee’s gross negligence, fraud or willful misconduct, the Trustee shall not be liable for any loss, liability or expense
    resulting from any error in the information or transmission of the funds.

   

  (b) This Agreement shall be governed by and construed
    and enforced in accordance with the laws of the State of New York, without giving effect to conflicts of law principles that would
    result in the application of the substantive laws of another jurisdiction. This Agreement may be executed in several original or
    facsimile counterparts, each one of which shall constitute an original, and together shall constitute but one instrument.

   

  (c) This Agreement contains the entire agreement
    and understanding of the parties hereto with respect to the subject matter hereof. Subject to Section 6(d), this Agreement or any
    provision hereof may only be changed, amended or modified (other than to correct a typographical error) by a writing signed by
    each of the parties hereto.

   

  
  
    	 

  

  
     

  

  
    

  (d) This Agreement or any provision hereof may
    only be changed, amended or modified pursuant to Section 6(c) hereof with the Consent of the Stockholders. For purposes of this
    Section 6(d), the “Consent of the Stockholders” means (i) receipt by the Trustee of a certificate from
    the inspector of elections of the stockholder meeting certifying that the Company’s stockholders of record as of a record
    date established in accordance with Section 213(a) of the Delaware General Corporation Law, as amended (or any successor rule),
    who hold sixty-five percent (65%) or more of all then outstanding shares of the Common Stock and Class B common stock, par value
    $0.0001 per share, of the Company voting together as a single class, have voted in favor of such change, amendment or modification,
    or (ii) the Company’s stockholders of record as of the record date who hold sixty-five percent (65%) or more of all then
    outstanding shares of the Common Stock and Class B common stock, par value $0.0001 per share, of the Company voting together as
    a single class, have delivered to the Trustee a signed writing approving such change, amendment or modification. No such amendment
    will affect any Public Stockholder who has otherwise properly indicated his, her or its election to redeem his, her or its shares
    of Common Stock in connection with a stockholder vote sought to amend this Agreement, including a corresponding change to the Company’s
    amended and restated certificate of incorporation. Except for any liability arising out of the Trustee’s gross negligence,
    fraud or willful misconduct, the Trustee may rely conclusively on the certification from the inspector or elections referenced
    above and shall be relieved of all liability to any party for executing the proposed amendment in reliance thereon.

   

  (e) The parties hereto consent to the jurisdiction
    and venue of any state or federal court located in the City of New York, State of New York, for purposes of resolving any disputes
    hereunder. AS TO ANY CLAIM, CROSS-CLAIM OR COUNTERCLAIM IN ANY WAY RELATING TO THIS AGREEMENT, EACH PARTY WAIVES THE RIGHT TO TRIAL
    BY JURY.

   

  (f) Any notice, consent or request to be given
    in connection with any of the terms or provisions of this Agreement shall be in writing and shall be sent by express mail or similar
    private courier service, by certified mail (return receipt requested), by hand delivery or by electronic mail:

   

  if to the Trustee, to:

   

  Continental Stock Transfer & Trust Company

    1 State Street, 30th Floor

    New York, NY 10004

    Attn: Francis Wolf and Celeste Gonzalez

    Email: fwolf@continentalstock.com

    cgonzalez@continentalstock.com

   

  if to the Company, to:

   

  HumanCo Acquisition Corp.

    P.O. Box 90608

  Austin, TX 78709

    Attn: Amy Zipper

  Email: amy@humanco.com

   

  in each case, with copies,
    which shall not constitute notice, to:

   

  Ropes & Gray LLP

  1211 Avenue of the Americas

  New York, NY 10036

  Attention: Paul Tropp

  Email: paul.tropp@ropesgray.com

   

  and

   

  Citigroup Global Markets Inc.

  388 Greenwich Street

  New York, NY 10013

  Attn: Pavan Bellur

  Email: pavan.bellur@citi.com

   

  
  
    	 

  

  
     

  

  
    

  and

   

  Davis Polk & Wardwell LLP

  450 Lexington Avenue

  New York, NY 10017

    Attn: Derek Dostal

  Email: derek.dostal@davispolk.com

   

  (g) Each of the Company and the Trustee hereby
    represents that it has the full right and power and has been duly authorized to enter into this Agreement and to perform its respective
    obligations as contemplated hereunder. The Trustee acknowledges and agrees that it shall not make any claims or proceed against
    the Trust Account, including by way of set-off, and shall not be entitled to any funds in the Trust Account under any circumstance.

   

  (h) This Agreement is the joint product of the
    Trustee and the Company and each provision hereof has been subject to the mutual consultation, negotiation and agreement of such
    parties and shall not be construed for or against any party hereto.

   

  (i) This Agreement may be executed in any number
    of counterparts, each of which shall be deemed to be an original, but all such counterparts shall together constitute one and the
    same instrument. Delivery of a signed counterpart of this Agreement by facsimile or electronic transmission shall constitute valid
    and sufficient delivery thereof.

   

  (j) Each of the Company and the Trustee hereby
    acknowledges and agrees that the Underwriter is a third party beneficiary of this Agreement.

   

  (k) Except as specified herein, no party to this
    Agreement may assign its rights or delegate its obligations hereunder to any other person or entity.

   

  [Signature Page Follows]

   

  
  
    	 

  

  
     

  

  
   

  IN WITNESS WHEREOF, the parties have
    duly executed this Investment Management Trust Agreement as of the date first written above.

   

  	 	CONTINENTAL STOCK TRANSFER &
	 	TRUST COMPANY, as Trustee
	 	 
	 	By: 	/s/ Francis Wolf
	 	Name:	 Francis Wolf
	 	Title:	 Vice President
	 	 	 
	 	HUMANCO ACQUISITION CORP. 
	 	 
	 	By:	/s/ Amy Zipper
	 	Name:	 Amy Zipper
	 	Title:	 Chief Operating Officer

   

  [Signature Page to Investment Management Trust
    Agreement] 

   

  
  
    	 

  

  
     

  

  
   

  SCHEDULE
        A

   

  	Fee Item	 	Time and method of payment	 	Amount	 
	Initial set-up fee	 	Initial closing of Offering by wire transfer	 	$	3,500.00	 
	Trustee administration fee	 	First year, initial closing of Offering by wire transfer, thereafter on the anniversary of the effective date of the Offering by wire transfer or check	 	$	10,000.00	 
	Transaction processing fee for disbursements to Company under Sections 1(i) and 1(j)	 	Billed to Company following disbursement made to Company under Section 1	 	$	250.00	 
	Paying Agent services as required pursuant to Sections 1(i) and 1(k)	 	Billed to Company upon delivery of service pursuant to Sections 1(i) and 1(k)	 	 	Prevailing rates	 

   

  
  
    	 

  

  
     

  

  
   

  EXHIBIT
        A

  [Letterhead of Company]

  [Insert date]

   

  Continental Stock Transfer & Trust Company

    1 State Street, 30th Floor

    New York, New York 10004

    Attn: Francis Wolf and Celeste Gonzalez

   

  Re: Trust Account - Termination Letter

   

  Mr. Wolf and Ms. Gonzalez:

   

  Pursuant to Section 1(i) of the Investment Management
    Trust Agreement between HumanCo Acquisition Corp. (the “Company”) and Continental Stock Transfer &
    Trust Company (the “Trustee”), dated as of December 9, 2020 (the “Trust Agreement”),
    this is to advise you that the Company has entered into an agreement with [__________] (the “Target Business”)
    to consummate a business combination with the Target Business (the “Business Combination”) on or about
    [insert date]. The Company shall notify you at least seventy-two (72) hours (or such shorter time as you may agree) in advance
    of the actual date fixed for the consummation of the Business Combination (the “Consummation Date”).
    Capitalized terms used but not defined herein shall have the meanings set forth in the Trust Agreement.

   

  In accordance with the terms of the Trust Agreement,
    we hereby authorize you to commence to liquidate all of the assets of the Trust Account and transfer the proceeds to a segregated
    account held by you on behalf of the Beneficiaries to the effect that, on the Consummation Date, all of the funds held in the Trust
    Account will be immediately available for transfer to the account or accounts that the Company shall direct on the Consummation
    Date (including as directed to it by the Underwriter (with respect to the Deferred Discount)). It is acknowledged and agreed that
    while the funds are on deposit in the Trust Account awaiting distribution, the Company will not earn any interest or dividends.

   

  On the Consummation Date (i) counsel for the
    Company shall deliver to you written notification that the Business Combination has been consummated, or will be consummated substantially
    concurrently with your transfer of funds to the accounts as directed by the Company (the “Notification”)
    and (ii) the Company shall deliver to you (a) a certificate of its Chief Executive Officer, Chief Financial Officer or Chief Operating
    Officer (the “Vote Verification Certificate”), which verifies either that (i) the Business Combination
    has been approved by a vote of the Company’s stockholders, if a vote is held or (ii) no vote of the Company’s stockholders
    for the approval of the Business Combination is required and none has been held, and (b) a joint written instruction signed by
    the Company and the Underwriter with respect to the transfer of the funds held in the Trust Account, including payment of amounts
    owed to Public Stockholders who have properly exercised their redemption rights and payment of the Deferred Discount to the Underwriter
    from the Trust Account (the “Instruction Letter”). You are hereby directed and authorized to transfer
    the funds held in the Trust Account immediately upon your receipt of the Notification, the Vote Verification Certificate and the
    Instruction Letter, in accordance with the terms of the Instruction Letter. In the event that certain deposits held in the Trust
    Account may not be liquidated by the Consummation Date without penalty, you will notify the Company in writing of the same and
    the Company shall direct you as to whether such funds should remain in the Trust Account and be distributed after the Consummation
    Date to the Company. Upon the distribution of all the funds, net of any payments necessary for reasonable unreimbursed expenses
    related to liquidating the Trust Account, your obligations under the Trust Agreement shall be terminated.

   

  In the event that the Business Combination is
    not consummated on the Consummation Date described in the notice thereof and we have not notified you on or before the original
    Consummation Date of a new Consummation Date, then upon receipt by you of written instructions from the Company, the funds held
    in the Trust Account shall be reinvested as provided in Section 1(c) of the Trust Agreement on the business day immediately following
    such original Consummation Date as set forth in such notice or as soon thereafter as possible.

   

  [Signature Page Follows]

   

  
  
    	 

  

  
     

  

  
    

  	 	Very truly yours,
	 	 
	 	HumanCo Acquisition Corp.
	 	 
	 	By: 	            
	 	Name:
	 	Title:

   

  cc: Citigroup Global Markets Inc.

   

  
  
    	 

  

  
     

  

  
   

  EXHIBIT
        B

  [Letterhead of Company]

  [Insert date]

   

  Continental Stock Transfer & Trust Company

    1 State Street, 30th Floor

    New York, New York 10004

    Attn: Francis Wolf and Celeste Gonzalez

   

  Re: Trust Account - Termination Letter

   

  Mr. Wolf and Ms. Gonzalez:

   

  Pursuant to Section 1(i) of the Investment Management
    Trust Agreement between HumanCo Acquisition Corp. (the “Company”) and Continental Stock Transfer &
    Trust Company (the “Trustee”), dated as of _________, 2020 (the “Trust Agreement”),
    this is to advise you that the Company has been unable to effect a business combination with a Target Business (the “Business
        Combination”) within the time frame specified in the Company’s amended and restated certificate of incorporation,
    as described in the Company’s Prospectus relating to the Offering. Capitalized terms used but not defined herein shall have
    the meanings set forth in the Trust Agreement.

   

  In accordance with the terms of the Trust Agreement,
    we hereby authorize you to liquidate all of the assets in the Trust Account and keep the total proceeds thereof in the Trust Account
    to await distribution to the Covered Stockholders. The Company has selected [_________, 20__]1
    as the effective date for the purpose of determining when the Covered Stockholders will be entitled to receive their share of the
    liquidation proceeds. You agree to be the Paying Agent of record and, in your separate capacity as Paying Agent, agree to distribute
    said funds directly to the Covered Stockholders in accordance with the terms of the Trust Agreement and the Company’s amended
    and restated certificate of incorporation. Upon the distribution of all the funds, net of any payments necessary for reasonable
    unreimbursed expenses related to liquidating the Trust Account, your obligations under the Trust Agreement shall be terminated,
    except to the extent otherwise provided in Section 1(i) of the Trust Agreement.

   

  	 	Very truly yours,
	 	 
	 	HumanCo Acquisition Corp.
	 	 
	 	By:	             
	 	Name:
	 	Title:

   

  cc: Citigroup Global Markets Inc.

   

  

  
  
     

  

  
  

  1 24 months from the closing of the Offering or at a
    later date, if extended. 

   

  
  
    	 

  

  
     

  

  
   

  EXHIBIT
        C

  [Letterhead of Company]

  [Insert date]

   

  Continental Stock Transfer & Trust Company

    1 State Street, 30th Floor

    New York, New York 10004

    Attn: Francis Wolf and Celeste Gonzalez

   

  Re: Trust Account - Withdrawal Instruction

   

  Mr. Wolf and Ms. Gonzalez:

   

  Pursuant to Section 1(j) of the Investment Management
    Trust Agreement between HumanCo Acquisition Corp. (the “Company”) and Continental Stock Transfer &
    Trust Company (the “Trustee”), dated as of December 9, 2020 (the “Trust Agreement”),
    the Company hereby requests that you deliver to the Company $[_____] of the interest income earned on the Property as of the date
    hereof. Capitalized terms used but not defined herein shall have the meanings set forth in the Trust Agreement.

   

  The Company needs such funds [to pay for the
    tax obligations as set forth on the attached tax return or tax statement]. In accordance with the terms of the Trust Agreement,
    you are hereby directed and authorized to transfer (via wire transfer) such funds promptly upon your receipt of this letter to
    the Company’s operating account at:

   

  [WIRE
        INSTRUCTION INFORMATION]

   

  	 	Very truly yours,
	 	 
	 	HumanCo Acquisition Corp.
	 	 
	 	By:	            
	 	Name:
	 	Title:

   

  cc: Citigroup Global Markets Inc.

   

  
  
    	 

  

  
     

  

  
   

  EXHIBIT
        D

  [Letterhead of Company]

  [Insert date]

   

  Continental Stock Transfer & Trust Company

    1 State Street, 30th Floor

    New York, New York 10004

    Attn: Francis Wolf and Celeste Gonzalez

   

  Re: Trust Account - Stockholder Redemption Withdrawal
      Instruction

   

  Mr. Wolf and Ms. Gonzalez:

   

  Pursuant to Section 1(k) of the Investment Management
    Trust Agreement between HumanCo Acquisition Corp. (the “Company”) and Continental Stock Transfer &
    Trust Company (the “Trustee”), dated as of December 9, 2020 (the “Trust Agreement”),
    the Company hereby requests that you deliver $[_____] of the principal and interest income earned on the Property as of the date
    hereof to a segregated account held by you on behalf of the Public Stockholders who have properly elected to have their Public
    Shares redeemed by the Company as described below. Capitalized terms used but not defined herein shall have the meanings set forth
    in the Trust Agreement.

   

  The Company needs such funds to pay the Public
    Stockholders who have properly elected to have their Public Shares redeemed by the Company in connection with a stockholder vote
    to approve an amendment to the Company’s amended and restated certificate of incorporation to modify the substance or timing
    of the ability of Public Stockholders to seek redemption in connection with an initial Business Combination or the Company’s
    obligation to redeem 100% of the Public Shares and CAVU Shares if the Company has not consummated an initial Business Combination
    within such time as is described in the Company’s amended and restated certificate of incorporation or to affect provisions
    of the Company’s amended and restated certificate of incorporation relating to the Company’s pre-initial Business Combination
    activity or related stockholder rights. As such, you are hereby directed and authorized to transfer (via wire transfer) such funds
    promptly upon your receipt of this letter to a segregated account held by you on behalf of such Public Stockholders.

   

  	 	Very truly yours,
	 	 
	 	HumanCo Acquisition Corp.
	 	 
	 	By:	              
	 	Name:
	 	Title:

   

  cc: Citigroup Global Markets Inc.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00318-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00318-of-00352.parquet"}]]